US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,643.42

+3.190.19%

Number of Gainers:13

Number of Losers:6

Number of Flat:- -

PE:- -

High:1,648.07

Open:1,639.91

Low:1,633.09

Close:1,640.23

Volume:97.84M

Turnover:5.31B

Market Cap:1.34T

Float Cap:1.32T

Loading ...

Nanexa Ab - to Receive USD 3 Mln Upfront and Entitled to up to USD 500 Million in Potential Milestone Payments

THOMSON REUTERS

Abbott Laboratories Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Eli Lilly & Co. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Top Midday Decliners

MT Newswires Live

Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says

MT Newswires Live

BRIEF-Pfizer Is Cutting Hundreds Of Jobs In Switzerland To Lower Costs- Bloomberg News

Pfizer Will Reduce Its Workforce in Switzerland to Roughly 70 by the End of This Year From 300- Bloomberg News

THOMSON REUTERS

Pfizer Is Cutting Hundreds of Jobs in Switzerland to Lower Costs- Bloomberg News

THOMSON REUTERS

Ocugen Showcases Gene Therapy Advances at Oppenheimer Movers in Rare Disease Summit

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

Pfizer Reports TUKYSA Combo Extends Progression-Free Survival in HER2+ Metastatic Breast Cancer

Tukysa Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients With Her2+ Metastatic Breast Cancer

THOMSON REUTERS

BRIEF-Pfizer Announces Results From Phase 3 HER2CLIMB-05 Trial Of TUKYSA

Pfizer: Tukysa, Trastuzumab & Pertuzumab Combination Demonstrated Manageable Safety Profile as First-Line Maintenance Therapy

THOMSON REUTERS

Pfizer: Key Secondary Endpoint of Overall Survival Not Mature at Time of Analysis but Showed Numerical Trend for Improvement With Tukysa

THOMSON REUTERS

Pfizer: Announced Results From Phase 3 Her2climb-05 Trial of Tukysa

THOMSON REUTERS

Pfizer: Tukysa, Trastuzumab & Pertuzumab Reduced Risk of Disease Progression/Death by 36% Compared to Trastuzumab & Pertuzumab Alone in Phase 3 Study

THOMSON REUTERS

Lakeland Industries Cut to Neutral From Buy by DA Davidson

Debate On Vaccine Safety Reaches Policy Stage - FDA Broadens Review Into Covid-19 Shot Risks In Adults

Fresenius Medical Care Appoints Charles Hugh-Jones as Global Chief Medical Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1643.4171,"timestamp":1766437199999,"preClose":1640.2305,"halted":0,"volume":97840269,"delay":0,"changeRate":0.001943,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":3.186646,"latestTime":"12-22 16:00:00 EST","open":1639.9099,"high":1648.0654,"low":1633.0945,"amount":5307737383.223429,"amplitude":0.009127,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766480400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.135902,"peRate":21.455987,"turnoverRate":0.006353,"increases":13,"decrements":6,"flats":0,"marketCap":1337784943615,"floatMarketCap":1318847922891.125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1648.0654,"amplitude":0.009127,"preClose":1640.2305,"low":1633.0945,"pbRate":"4.135902","latestPrice":1643.4171,"volume":97840269,"delay":0,"open":1639.9099,"prevYearClose":1274.8187,"prevWeekClose":1640.2305,"prevMonthClose":1658.0673,"prevQuarterClose":1508.8958,"fiveDayClose":1671.2278,"twentyDayClose":1631.0314,"sixtyDayClose":1468.6451,"secType":"PLATE","market":"US","turnoverRate":0.006353,"peRate":21.455987,"marketCap":1337784943615,"floatMarketCap":1318847922891.125,"timestamp":1766437199999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":13,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590855319","title":"Nanexa Ab - to Receive USD 3 Mln Upfront and Entitled to up to USD 500 Million in Potential Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2590855319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590855319?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:35","pubTimestamp":1765402501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUC8XMBVY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNA","BK4501","BK4532","BK4568","BK4534","BK4548","BK4585","BK4533","BK4588","BK4139","BK4551"],"gpt_icon":0},{"id":"2590855346","title":"Abbott Laboratories Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2590855346","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590855346?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:34","pubTimestamp":1765402440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  rallied 1.07% to $122.55 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.67% to 6,886.68 and the Dow Jones Industrial Average  rising 1.05% to 48,057.75.The stock's rise snapped a three-day losing streak.Abbott Laboratories closed 13.23% below its 52-week high of $141.23, which the company achieved on March 4th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 3.29% to $206.54, Pfizer Inc.  rose 1.78% to $25.78, and Merck & Co. Inc.  rose 0.75% to $97.62.Data source: Dow Jones Market Data, FactSet. Data compiled December 10, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","LU2023250504.SGD","LU1069347547.HKD","BK4516","LU0985320562.USD","IE0009355771.USD","LU0306807586.USD","IE00B1BXHZ80.USD","BK4504","IE00BBT3K403.USD","LU1074936037.SGD","LU1506573853.SGD","LU0965509101.SGD","LU0208291251.USD","IE00B42XCP33.USD","LU1721429741.USD","LU2471134952.CNY","LU0225284248.USD","LU2237957902.USD","LU2430703251.USD","LU0265550359.USD","LU1989772923.USD","BK4532","LU1934455277.USD","LU0225771236.USD","LU1059921491.USD","IE00BZ1G4Q59.USD","LU0098860793.USD","LU1162221912.USD","LU1221951046.USD","LU2347655156.SGD","LU2361044865.SGD","BK4566","LU0211331839.USD","LU1035773651.USD","LU1093756168.USD","LU2106854487.HKD","LU1778281490.HKD","LU2125154935.USD","LU0122379950.USD","LU0882574055.USD","IE00BLSP4452.SGD","LU1037948541.HKD","IE0034235303.USD","LU0795875086.SGD","LU1116320901.HKD","IE00BVYPNW00.USD","SGXZ57979304.SGD","IE00B3PB1722.GBP","LU1066051498.USD","BK4599","LU1585245621.USD","SGXZ41872573.SGD","LU2361045086.USD","LU2471134523.USD","LU1244550577.SGD","SG9999001176.SGD","LU1066053197.SGD","IE00BLSP4239.USD","BK4559","LU2750360997.AUD","LU1941712264.USD","LU1941712348.USD","IE00B2B36J28.USD","LU1674673691.USD","LU1244550494.USD","LU2324357040.USD","SG9999014559.SGD","LU2505996681.GBP","LU1894683264.USD","LU0289739699.SGD","LU0006306889.USD","LU2471134796.USD","LU2125154778.USD","LU2129689431.USD","LU0170899867.USD","LU0234572021.USD","LU1929549753.HKD","LU2360032135.SGD","LU1280957306.USD","LU1914381329.SGD","LU0203347892.USD","SG9999002232.USD","LU1571399168.USD","LU1261432733.SGD","IE000M9KFDE8.USD","LU1066051225.USD","LU1221951129.SGD","LU2023250843.SGD","LU1116320737.USD","LU0889566641.SGD","LU0868494617.USD","LU1718418525.SGD","BK4534","BK4007","LU0321505439.SGD","LU2129689605.HKD","LU2133065610.SGD","LU2237957811.SGD","ABT","SG9999014567.USD","LU1989771016.USD","LU1244550221.USD","LU1093756325.SGD","LU1066051811.HKD","IE00B19Z3581.USD","LU1699723380.USD","LU0320765489.SGD","LU1983299246.USD","LU0792757196.USD","LU0238689110.USD","IE0002141913.USD","LU0345770993.USD","SG9999003800.SGD","LU0965509283.SGD","LU1917777945.USD","LU1732800096.USD","LU2592432038.USD","SG9999015341.SGD","LU0114720955.EUR","LU0058720904.USD","LU2211815571.USD","IE00B3T34201.USD","LU0234570918.USD","LU0345769128.USD","LU1883839398.USD","LU2361044949.HKD","LU2602419157.SGD","LU0432979614.USD","LU1691799644.USD","SG9999014542.SGD","LU0070302665.USD","IE00BGHQF631.EUR","LU0965509010.AUD","IE00BVYPNV92.GBP","LU1989772840.SGD","LU1934455194.USD","SG9999001440.SGD","IE00BJJMRZ35.SGD","BK4550","LU1032955483.USD","LU2112291526.USD","SG9999013999.USD","LU1291159041.SGD","BK4568","LU2461242641.AUD","IE00B4R5TH58.HKD","LU2430703095.HKD","BK4533","LU1732799900.SGD","SG9999001176.USD","LU1989763427.SGD","LU0965508806.USD","IE00BFTCPJ56.SGD","LU2505996509.AUD","IE00BFXG1179.USD","SG9999004303.SGD","LU1061106388.HKD","LU0912757837.SGD","LU2129689514.USD","LU1989763690.USD","LU1974910355.USD","LU1894683348.USD","LU0345769631.USD","LU2430703178.SGD","SGXZ23171101.USD","BK4585","BK4581","LU0106261372.USD","LU0320765646.SGD","SG9999011175.SGD","LU0203345920.USD","IE00B7SZLL34.SGD","IE00BDGV0183.EUR","LU2471134879.HKD","LU1934455863.HKD","LU1674673428.USD","IE00BN8TJ469.HKD","LU1430594728.SGD","LU0321505868.SGD","IE00BKVL7J92.USD","BK4082","BK4592","LU0861579265.USD","LU0985481810.HKD","LU0070217475.USD","LU2089984988.USD","LU2468319806.SGD","LU1935042991.SGD","LU0466842654.USD","SG9999002224.SGD","LU0456855351.SGD","IE0002270589.USD","LU0265550946.USD","LU2750360641.GBP","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU1032466523.USD","LU1037948897.HKD","LU1023059063.AUD","LU1267930813.SGD","LU1057294990.SGD","LU0795875169.SGD","IE00BSNM7G36.USD","LU1496350502.SGD","LU1721429402.USD","LU1196500208.SGD","BK4588","LU0640476718.USD","SG9999015358.SGD","LU0345770308.USD","SG9999014575.USD","LU0306806265.USD"],"gpt_icon":0},{"id":"2590553938","title":"Eli Lilly & Co. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2590553938","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590553938?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:31","pubTimestamp":1765402260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Eli Lilly & Co.  rose 1.16% to $993.64 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.67% to 6,886.68 and the Dow Jones Industrial Average  rising 1.05% to 48,057.75.The stock's rise snapped a nine-day losing streak.Eli Lilly & Co. closed 10.64% short of its 52-week high of $1,111.99, which the company achieved on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 3.29% to $206.54, Pfizer Inc.  rose 1.78% to $25.78, and AbbVie Inc.  rose 0.98% to $225.18.Data source: Dow Jones Market Data, FactSet. Data compiled December 10, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0096364046.USD","LU0310799852.SGD","LU1066053197.SGD","LU2347655156.SGD","LU2089984988.USD","LU1506573853.SGD","LU0889565916.HKD","IE0004445015.USD","LU1061106388.HKD","LU0310800379.SGD","LU1066051498.USD","LU2361045086.USD","LU2237438978.USD","LU0225771236.USD","LU1244550221.USD","LU1868837136.USD","LU2112291526.USD","LU1917777945.USD","BK4585","IE00BBT3K403.USD","LU0109391861.USD","LU2505996681.GBP","LU1934455277.USD","IE00BFXG1179.USD","IE00B42XCP33.USD","LU2746668461.USD","LU0353189763.USD","LU1868836591.USD","IE00B7SZLL34.SGD","IE000M9KFDE8.USD","BK4581","LU1585245621.USD","SG9999018865.SGD","LU2552382132.HKD","IE00BJJMRX11.SGD","LU1868836914.USD","LU0114720955.EUR","SGXZ57979304.SGD","IE00BKDWB100.SGD","LU0889566641.SGD","LU0471298694.HKD","LU0238689110.USD","LU2468319806.SGD","LU0109394709.USD","BK4534","LU0320765992.SGD","LU1732799900.SGD","LU0823416689.USD","BK4532","IE00B775H168.HKD","IE00BJJMRZ35.SGD","LU0061475181.USD","SG9999015945.SGD","LU2265009873.SGD","IE00BVYPNV92.GBP","SG9999001176.USD","LU1221951046.USD","SG9999015978.USD","LU2430703178.SGD","LU0820561909.HKD","LU1127390331.HKD","LU2089284900.SGD","SG9999018857.SGD","LU2361044949.HKD","IE00BLSP4452.SGD","LU2168564065.EUR","LU2746668974.SGD","LU1280957306.USD","LU0985320562.USD","LU2430703251.USD","IE00B7KXQ091.USD","LU0203202063.USD","LU0708995401.HKD","LU1894683264.USD","IE00BWXC8680.SGD","IE00B19Z3B42.SGD","LU0354030511.USD","LU0006306889.USD","LU0689472784.USD","SG9999014914.USD","LU0943347566.SGD","BK4516","SG9999015986.USD","BK4559","BK4139","LU2750360641.GBP","IE00BZ1G4Q59.USD","LU1064131342.USD","LU0321505868.SGD","LU2471134796.USD","LU2237443549.SGD","LU1059921491.USD","LU2168564149.EUR","LU1032466523.USD","LU2023250504.SGD","IE00B3PB1722.GBP","LU0323591593.USD","IE00BK4W5M84.HKD","LU0029864427.USD","IE00BJLML261.HKD","LU0058720904.USD","LU2360106947.USD","LU1162221912.USD","LU0203201768.USD","LU0861579265.USD","LU0097036916.USD","LU1548497426.USD","LU0256863811.USD","LU1267930573.SGD","LU1057294990.SGD","LU0792757196.USD","LU0985481810.HKD","LU1551013425.SGD","IE00B3T34201.USD","IE00BLSP4239.USD","LU2237443465.HKD","LU1035775433.USD","LU1066051225.USD","LU2237443895.HKD","LU0234570918.USD","LU0306807586.USD","LU1261432733.SGD","LU2430703095.HKD","LU1291159041.SGD","SG9999017495.SGD","LU0094547139.USD","LU0203347892.USD","LU0553294199.USD","LU1989772840.SGD","BK4504","LU2461242641.AUD","LU1023059063.AUD","LU0661504455.SGD","LU1839511570.USD","IE0004445239.USD","SG9999002232.USD","LU1674673428.USD","LU0321505439.SGD","IE00B1BXHZ80.USD","LU1778281490.HKD","LU0320765059.SGD","SG9999014898.SGD","LU0795875169.SGD","IE00BDGV0183.EUR","LU2462157665.USD","LU2063271972.USD","LU0882574139.USD","LU2168564222.USD","LU1267930813.SGD","LU0234572021.USD","IE00B2B36J28.USD","LU1430594728.SGD","SG9999003800.SGD","LU0128525929.USD","BK4599","IE00BKPKM429.USD","LU0965508806.USD","LU0868494617.USD","LU1366192091.USD","LU2750360997.AUD","IE0034235303.USD","LU0965509010.AUD","LU0211328371.USD","LU0640476718.USD","LU0158827948.USD","LU1988902786.USD","LU2505996509.AUD","LU1496350502.SGD","LU0965509101.SGD","IE00BJJMRY28.SGD","SG9999001440.SGD","LU1496350171.SGD","LU2129689514.USD","LU0417517546.SGD","LU0306806265.USD","LU2168564495.EUR","LU2592432038.USD","LU1066051811.HKD","LU1003077747.HKD","LU1093756168.USD","LU0823434740.USD","LU0354030438.USD","LU2237443622.USD","LU2087621335.USD","IE00BKVL7J92.USD","IE00BK4W5L77.USD","LU1732800096.USD","LU0266013472.USD","LU1037948541.HKD","LU2106854487.HKD","LU1934455863.HKD","LU0949170772.SGD","LU1623119135.USD","LU1267930730.SGD","LU0965509283.SGD","IE0009355771.USD","IE00BN29S564.USD","LU0122379950.USD","LU2491050154.USD","LU1983299246.USD","LU0545039389.USD","IE00B4R5TH58.HKD","LU2491049909.HKD","SGXZ51526630.SGD","BK4592","LU0823434583.USD","IE00B4JS1V06.HKD","LU0353189680.USD","LU1894683348.USD","LU0345769128.USD","LU0289739699.SGD","BK4568","BK4550","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU1037948897.HKD","LU0079474960.USD","LU1244550577.SGD","LU2237443978.SGD","LU2417539215.USD","LU1232071149.USD","BK4566","LU1989772923.USD","SGXZ31699556.SGD","LU2133065610.SGD","LU1221951129.SGD","LU0320765646.SGD","LU1267930490.SGD","LU1674673691.USD","LU0345770308.USD","SG9999014880.SGD","LU0471298777.SGD","LU2108987350.USD","LU2552382215.SGD","GB00BDT5M118.USD","LU1868837300.USD","LU0738911758.USD","LU1914381329.SGD","LU2361044865.SGD","LLY","LU2089283258.USD","IE00BN8TJ469.HKD","LU0672654240.SGD","LU2237443382.USD","BK4533","LU0456855351.SGD","LU1069344957.HKD","LU0820561818.USD","IE0002141913.USD","LU0689626769.HKD","LU0786609619.USD","LU1032955483.USD","LU1934455194.USD","LU1935042991.SGD","LU1720051108.HKD","IE00BVYPNW00.USD","LU2491050071.SGD","SG9999013999.USD","LU1814569148.SGD","LU2357305700.SGD","LU2552382058.USD","LU2264538146.SGD","SG9999011175.SGD","LU0170899867.USD","LU2129689605.HKD","LU1720051017.SGD","SG9999001176.SGD","LU0345769631.USD","LU1974910355.USD","LU0912757837.SGD","LU0070217475.USD","SGXZ81514606.USD","SG9999014906.USD","LU0106261372.USD","LU2168563687.JPY","IE00BFSS8Q28.SGD","IE00BGHQF631.EUR","LU2023251221.USD","LU2236285917.USD","LU1989771016.USD","BK4007","LU0708994859.HKD","LU0345770993.USD","LU1074936037.SGD","LU1712237335.SGD","LU2456880835.USD","IE0002270589.USD","LU1868836757.USD","LU2324357040.USD","LU0198837287.USD","IE00BFSS7M15.SGD","IE00B19Z3581.USD","LU0211327993.USD","IE00BFTCPJ56.SGD","LU0795875086.SGD","LU2602419157.SGD","LU0432979614.USD","LU2471134523.USD","LU2211815571.USD","LU0385154629.USD","LU0882574055.USD","LU0098860793.USD","LU1883839398.USD","LU2087625088.SGD","IE00B1XK9C88.USD","LU2471134952.CNY","LU1323610961.USD","LU0256863902.USD","LU0124676726.USD","LU1244550494.USD","LU1929549753.HKD","LU0225284248.USD","LU1804176565.USD","LU1718418525.SGD","LU2129689431.USD","SG9999002224.SGD","SGXZ99366536.SGD","LU0203345920.USD","LU2471134879.HKD","LU1551013342.USD","LU0316494557.USD","LU0466842654.USD","SG9999015952.SGD","LU1196500208.SGD","LU1093756325.SGD","IE0005OL40V9.USD"],"gpt_icon":1},{"id":"2590537925","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2590537925","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590537925?lang=en_us&edition=fundamental","pubTime":"2025-12-11 03:37","pubTimestamp":1765395457,"startTime":"0","endTime":"0","summary":"Treasure Global  said Wednesday it expects to raise $2.5 million from a registered direct offering of 250,000 common shares.Shares sank 43% following an increase in intraday trading volume to about 1.3 million from a daily average of about 760,000.Lakeland Industries  shares slumped 39% amid heavy trading after the company reported late Tuesday it swung to a fiscal Q3 loss.Intraday trading volume soared to over 2.3 million shares from a daily average of about 131,000.MIND Technology  stock was down 17% after the company reported lower fiscal Q3 earnings and revenue late Tuesday.Shares slumped 25% as intraday trading volume soared to about 1.1 million from a daily average of about 258,000.Price: 8.96, Change: -6.76, Percent Change: -43.00","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B66KJ199.SGD","IE00B19Z4B17.USD","MIND","IE00B7SZL793.SGD","IE0031619046.USD","BK4568","LAKE","BK4009","BK4179","TGL","BK4202"],"gpt_icon":1},{"id":"2590953199","title":"Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2590953199","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590953199?lang=en_us&edition=fundamental","pubTime":"2025-12-11 01:03","pubTimestamp":1765386224,"startTime":"0","endTime":"0","summary":"Legend Biotech's  share price weakness after the release of data from a phase 3 trial of a rival treatment for relapsed or refractory multiple myeloma is \"overdone\" as Legend's Carvykti can still be the preferred option, RBC Capital Markets said in a note emailed Wednesday.Johnson & Johnson's  teclistamab plus daratumumab therapy showed \"promising\" efficacy, the investment firm said.But Legend's Carvykti is still potentially the \"highest efficacy option, with one-and-done convenience, continued growth and penetration into early lines and the community setting,\" according to the note.The investment firm said it would be a buyer on Legend's weakness, and it expects near-term profitability for the company and further growth next year.RBC has an outperform rating on Legend stock and $74 price target.Price: 23.47, Change: -0.41, Percent Change: -1.73","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0070217475.USD","LU2430703251.USD","IE00BLSP4239.USD","LU1718418525.SGD","IE00BKVL7J92.USD","IE0002141913.USD","BK4559","LU1894683348.USD","IE00BLSP4452.SGD","LU2471134879.HKD","LU0912757837.SGD","LU2112291526.USD","LU0345770308.USD","IE00BSNM7G36.USD","LU2430703178.SGD","LU2602419157.SGD","BK4139","LU1032955483.USD","BK4581","LU1244550577.SGD","IE00BFTCPJ56.SGD","IE00BN8TJ469.HKD","LU0289739699.SGD","LU1023059063.AUD","LU2089984988.USD","LU1732799900.SGD","IE000M9KFDE8.USD","LU2505996681.GBP","BK4505","BK4504","JNJ","LEGN","LU2471134952.CNY","LU2505996509.AUD","IE00B3PB1722.GBP","LU0234570918.USD","BK4550","IE00BZ1G4Q59.USD","BK4568","LU2133065610.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4585","IE00BGHQF631.EUR","LU0640476718.USD","LU0345770993.USD","LU1280957306.USD","IE0034235303.USD","LU1914381329.SGD","IE00B42XCP33.USD"],"gpt_icon":0},{"id":"2590392355","title":"BRIEF-Pfizer Is Cutting Hundreds Of Jobs In Switzerland To Lower Costs- Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2590392355","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590392355?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:32","pubTimestamp":1765384325,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer Is Cutting Hundreds Of Jobs In Switzerland To Lower Costs- Bloomberg NewsDec 10 (Reuters) - PFIZER IS CUTTING HUNDREDS OF JOBS IN SWITZERLAND TO LOWER COSTS- BLOOMBERG NEWSPFIZER WILL RED","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3689c0d91b1a665d6a6bb194da9a5eeb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG18O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","LU0321505439.SGD","LU0985481810.HKD","SG9999002224.SGD","BK4599","IE00BBT3K403.USD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0306806265.USD","SG9999003800.SGD","LU1066053197.SGD","IE0002270589.USD","BK4585","IE00BLSP4239.USD","LU0234572021.USD","LU1894683348.USD","LU0225284248.USD","LU0122379950.USD","BK4581","IE00B19Z3581.USD","BK4007","LU0306807586.USD","IE00BLSP4452.SGD","SG9999001176.USD","BK4592","SG9999001176.SGD","LU0289739699.SGD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0170899867.USD","LU1023059063.AUD","SG9999011175.SGD","LU1883839398.USD","BK4588","SGXZ57979304.SGD","BK4534","BK4550","LU0456855351.SGD","LU1057294990.SGD","LU0225771236.USD","BK4568","LU0868494617.USD","SG9999013999.USD","LU1066051498.USD","SG9999002232.USD","BK4533"],"gpt_icon":1},{"id":"2590391415","title":"Pfizer Will Reduce Its Workforce in Switzerland to Roughly 70 by the End of This Year From 300- Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2590391415","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590391415?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:28","pubTimestamp":1765384130,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3689c0d91b1a665d6a6bb194da9a5eeb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG18O:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","BK4585","SG9999002224.SGD","LU1883839398.USD","BK4534","BK4533","SG9999001176.SGD","LU0868494617.USD","BK4568","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4588","LU0225771236.USD","LU1066051498.USD","SG9999013999.USD","PFE","SG9999003800.SGD","IE0002270589.USD","LU0306806265.USD","LU0289739699.SGD","SGXZ57979304.SGD","LU0122379950.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0234572021.USD","BK4550","LU0306807586.USD","IE00BBT3K403.USD","BK4599","LU0058720904.USD","LU0170899867.USD","LU0321505439.SGD","LU1066053197.SGD","SG9999002232.USD","SG9999001176.USD","LU0456855351.SGD","SG9999011175.SGD","LU1894683348.USD","BK4007","LU1057294990.SGD","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4592","LU1894683264.USD","LU0225284248.USD","LU0321505868.SGD","BK4581"],"gpt_icon":0},{"id":"2590196539","title":"Pfizer Is Cutting Hundreds of Jobs in Switzerland to Lower Costs- Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2590196539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590196539?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:28","pubTimestamp":1765384130,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3689c0d91b1a665d6a6bb194da9a5eeb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG18O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4592","IE00BBT3K403.USD","BK4550","SG9999002232.USD","LU0306806265.USD","IE00BLSP4239.USD","LU0985481810.HKD","LU0234572021.USD","SG9999003800.SGD","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999013999.USD","BK4599","LU0058720904.USD","SG9999001176.SGD","LU0868494617.USD","LU0321505439.SGD","LU1894683348.USD","LU1894683264.USD","IE00BLSP4452.SGD","LU1883839398.USD","SG9999002224.SGD","SG9999011175.SGD","LU1066053197.SGD","LU1023059063.AUD","BK4533","BK4581","LU1057294990.SGD","BK4534","LU0321505868.SGD","BK4588","LU0122379950.USD","BK4007","IE0002270589.USD","LU0306807586.USD","IE00B19Z3581.USD","LU0170899867.USD","IE000M9KFDE8.USD","PFE","LU0289739699.SGD","LU1066051498.USD","LU0456855351.SGD","LU0225284248.USD","SG9999001176.USD","BK4585","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2590538718","title":"Ocugen Showcases Gene Therapy Advances at Oppenheimer Movers in Rare Disease Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2590538718","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590538718?lang=en_us&edition=fundamental","pubTime":"2025-12-10 22:20","pubTimestamp":1765376409,"startTime":"0","endTime":"0","summary":"Ocugen Inc. will participate in a fireside chat titled \"Fireside Chat with Aldeyra and Ocugen: Setting Sights on Inherited Retinal Dystrophies\" on Thursday, December 11, 2025. The event will take place from 9:45 to 10:05 a.m. ET in the Second Floor Ballroom, Track 1. Additionally, Ocugen's executive team will conduct one-on-one meetings with investors to discuss the company's business and clinical development strategy and upcoming catalysts in 2026. Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen, will also present at the Oppenheimer Movers in Rare Disease Summit at the Sofitel New York on the same day.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news bri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL2DMtsB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4139","NDAQ","BK4563","IE00B64PRP62.GBP","BK4568","BK4112","SG9999014021.USD","SG9999014039.USD","SG9999014005.SGD","OCGN","SG9999014013.SGD","BK4585","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD"],"gpt_icon":0},{"id":"2590533942","title":"Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2590533942","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590533942?lang=en_us&edition=fundamental","pubTime":"2025-12-10 22:20","pubTimestamp":1765376400,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Dec.  10, 2025  (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/10/3203253/0/en/Ocugen-CEO-to-Present-at-Oppenheimer-Movers-in-Rare-Disease-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCGN","BK4568","BK4211","BK4563","BK4127","BK4139","OPY","SMMF"],"gpt_icon":0},{"id":"2590587947","title":"Pfizer Reports TUKYSA Combo Extends Progression-Free Survival in HER2+ Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590587947","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590587947?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:15","pubTimestamp":1765372521,"startTime":"0","endTime":"0","summary":"Pfizer Inc. announced detailed results from the Phase 3 HER2CLIMB-05 trial evaluating TUKYSA  as part of an investigational first-line maintenance treatment in patients with HER2-positive metastatic breast cancer. The study demonstrated that the combination of TUKYSA, trastuzumab, and pertuzumab resulted in a 35.9% reduction in the risk of disease progression or death compared to trastuzumab and pertuzumab alone. Median progression-free survival was extended by 8.6 months in the TUKYSA arm. The safety profile was generally consistent with known effects of the individual therapies, with higher rates of asymptomatic Grade ≥3 liver transaminases noted. These results have been published in the Journal of Clinical Oncology and presented at the 48th San Antonio Breast Cancer Symposium.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL2JCkvM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","PFE","SG9999011175.SGD","LU0321505439.SGD","LU0289739699.SGD","LU0306806265.USD","SGXZ57979304.SGD","SG9999013999.USD","SG9999002224.SGD","BK4550","BK4588","SG9999001176.SGD","LU1894683348.USD","IE000M9KFDE8.USD","SG9999001176.USD","BK4585","IE00BLSP4452.SGD","LU0234572021.USD","SG9999003800.SGD","BK4533","BK4581","LU0170899867.USD","LU1883839398.USD","IE0002270589.USD","BK4568","IE00BBT3K403.USD","IE00BLSP4239.USD","LU1894683264.USD","BK4592","IE00B19Z3B42.SGD","LU0868494617.USD","LU0225771236.USD","BK4534","LU0122379950.USD","SG9999002232.USD","BK4007","LU0321505868.SGD","LU0456855351.SGD","LU1057294990.SGD","LU1066053197.SGD","LU1066051498.USD","LU1023059063.AUD","IE00B19Z3581.USD","LU0306807586.USD","LU0985481810.HKD","LU0058720904.USD","BK4599"],"gpt_icon":1},{"id":"2590058796","title":"Tukysa Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients With Her2+ Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590058796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590058796?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:15","pubTimestamp":1765372505,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG05G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","BK4581","LU0306807586.USD","LU0225771236.USD","IE00BBT3K403.USD","BK4599","BK4568","IE00B19Z3B42.SGD","IE00BLSP4239.USD","SG9999003800.SGD","LU0456855351.SGD","BK4550","SG9999001176.SGD","LU1023059063.AUD","LU0868494617.USD","LU1066051498.USD","SG9999002232.USD","LU1066053197.SGD","LU1894683264.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999013999.USD","SG9999011175.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0321505868.SGD","BK4585","IE00BLSP4452.SGD","BK4533","LU0234572021.USD","LU1894683348.USD","IE0002270589.USD","SG9999002224.SGD","LU0306806265.USD","LU0289739699.SGD","PFE","LU0122379950.USD","BK4592","BK4007","LU0170899867.USD","BK4588","BK4534","LU1057294990.SGD","LU0225284248.USD","LU0321505439.SGD","SG9999001176.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"2590874435","title":"BRIEF-Pfizer Announces Results From Phase 3 HER2CLIMB-05 Trial Of TUKYSA","url":"https://stock-news.laohu8.com/highlight/detail?id=2590874435","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590874435?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:15","pubTimestamp":1765372504,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer Announces Results From Phase 3 HER2CLIMB-05 Trial Of TUKYSADec 10  - Pfizer Inc PFE.N:PFIZER: ANNOUNCED RESULTS FROM PHASE 3 HER2CLIMB-05 TRIAL OF TUKYSAPFIZER: TUKYSA, TRASTUZUMAB & PERTUZUMAB REDUCED RISK OF DISEASE PROGRESSION/DEATH BY 36% COMPARED TO TRASTUZUMAB & PERTUZUMAB ALONE IN PHASE 3 STUDYPFIZER: TUKYSA, TRASTUZUMAB & PERTUZUMAB COMBINATION DEMONSTRATED MANAGEABLE SAFETY PROFILE AS FIRST-LINE MAINTENANCE THERAPYPFIZER: KEY SECONDARY ENDPOINT OF OVERALL SURVIVAL NOT MATURE AT TIME OF ANALYSIS BUT SHOWED NUMERICAL TREND FOR IMPROVEMENT WITH TUKYSAFurther company coverage: PFE.N ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nP8N3W406A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0289739699.SGD","IE00B19Z3581.USD","BK4585","LU0122379950.USD","LU0225771236.USD","LU0321505439.SGD","IE0002270589.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU1894683348.USD","SG9999001176.SGD","SG9999011175.SGD","BK4534","LU0170899867.USD","BK4588","IE00BLSP4239.USD","SG9999002224.SGD","IE00BBT3K403.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU1057294990.SGD","BK4599","SG9999013999.USD","LU0058720904.USD","BK4581","BK4568","BK4550","LU1023059063.AUD","SG9999001176.USD","BK4007","LU0306806265.USD","BK4533","LU1894683264.USD","LU1883839398.USD","LU1066053197.SGD","LU0456855351.SGD","SG9999002232.USD","LU0225284248.USD","BK4592","PFE","LU0306807586.USD","LU0321505868.SGD","SG9999003800.SGD","SGXZ57979304.SGD","LU0868494617.USD"],"gpt_icon":1},{"id":"2590993587","title":"Pfizer: Tukysa, Trastuzumab & Pertuzumab Combination Demonstrated Manageable Safety Profile as First-Line Maintenance Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2590993587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590993587?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:15","pubTimestamp":1765372500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nP8N3W406A:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505868.SGD","SG9999003800.SGD","BK4007","LU0122379950.USD","BK4588","LU1023059063.AUD","LU0225284248.USD","IE000M9KFDE8.USD","LU0306806265.USD","SG9999001176.SGD","IE00B19Z3581.USD","LU0985481810.HKD","LU1894683348.USD","BK4533","SG9999001176.USD","SG9999002224.SGD","BK4534","IE00B19Z3B42.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU1066053197.SGD","LU1883839398.USD","LU1057294990.SGD","IE0002270589.USD","SG9999013999.USD","SGXZ57979304.SGD","LU0456855351.SGD","LU0234572021.USD","LU0170899867.USD","LU0225771236.USD","SG9999002232.USD","LU0321505439.SGD","BK4568","BK4585","PFE","BK4599","BK4550","IE00BLSP4452.SGD","SG9999011175.SGD","BK4581","LU1894683264.USD","LU1066051498.USD","LU0058720904.USD","LU0289739699.SGD","BK4592","LU0868494617.USD","LU0306807586.USD"],"gpt_icon":0},{"id":"2590879535","title":"Pfizer: Key Secondary Endpoint of Overall Survival Not Mature at Time of Analysis but Showed Numerical Trend for Improvement With Tukysa","url":"https://stock-news.laohu8.com/highlight/detail?id=2590879535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590879535?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:15","pubTimestamp":1765372500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nP8N3W406A:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0306807586.USD","IE00BBT3K403.USD","SG9999003800.SGD","LU1894683348.USD","BK4585","BK4581","SG9999011175.SGD","LU1894683264.USD","LU0289739699.SGD","LU0225284248.USD","LU0058720904.USD","LU0170899867.USD","LU1883839398.USD","LU0234572021.USD","LU0225771236.USD","LU0321505868.SGD","IE00B19Z3581.USD","BK4592","LU0985481810.HKD","SG9999002232.USD","LU0122379950.USD","IE00BLSP4452.SGD","SG9999002224.SGD","IE000M9KFDE8.USD","LU0456855351.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU1057294990.SGD","BK4550","LU0868494617.USD","BK4534","BK4007","LU0321505439.SGD","LU1066051498.USD","PFE","SG9999013999.USD","BK4568","BK4588","BK4599","SG9999001176.SGD","BK4533","SG9999001176.USD","LU1066053197.SGD","SGXZ57979304.SGD","LU0306806265.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2590879375","title":"Pfizer: Announced Results From Phase 3 Her2climb-05 Trial of Tukysa","url":"https://stock-news.laohu8.com/highlight/detail?id=2590879375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590879375?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:15","pubTimestamp":1765372500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nP8N3W406A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0456855351.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1883839398.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","SG9999003800.SGD","IE00B19Z3581.USD","PFE","BK4588","LU0306806265.USD","LU0321505439.SGD","LU0306807586.USD","LU0289739699.SGD","BK4533","SG9999002232.USD","BK4550","LU0122379950.USD","LU0868494617.USD","LU0985481810.HKD","IE00BLSP4452.SGD","BK4599","SG9999001176.SGD","BK4568","SG9999001176.USD","IE0002270589.USD","BK4007","LU1894683348.USD","LU1066053197.SGD","IE000M9KFDE8.USD","LU0225771236.USD","BK4592","LU0234572021.USD","SG9999013999.USD","BK4581","LU0170899867.USD","LU0321505868.SGD","SG9999011175.SGD","LU0058720904.USD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","IE00BLSP4239.USD","BK4534","LU1894683264.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2590587961","title":"Pfizer: Tukysa, Trastuzumab & Pertuzumab Reduced Risk of Disease Progression/Death by 36% Compared to Trastuzumab & Pertuzumab Alone in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2590587961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590587961?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:15","pubTimestamp":1765372500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nP8N3W406A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PFE","IE00BLSP4239.USD","SG9999001176.SGD","BK4581","IE000M9KFDE8.USD","SG9999001176.USD","LU0868494617.USD","IE00BBT3K403.USD","LU1894683264.USD","SG9999011175.SGD","SG9999002232.USD","LU1066051498.USD","BK4007","BK4585","LU0456855351.SGD","SG9999003800.SGD","LU0985481810.HKD","IE00B19Z3B42.SGD","LU0225771236.USD","BK4568","IE0002270589.USD","LU0321505439.SGD","SGXZ57979304.SGD","BK4599","LU0321505868.SGD","SG9999013999.USD","LU1066053197.SGD","SG9999002224.SGD","LU0289739699.SGD","BK4550","LU0225284248.USD","LU1057294990.SGD","BK4533","BK4534","BK4588","LU1023059063.AUD","LU0058720904.USD","LU0234572021.USD","LU0170899867.USD","IE00B19Z3581.USD","LU1894683348.USD","LU0306806265.USD","LU1883839398.USD","LU0122379950.USD","BK4592","LU0306807586.USD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2590587916","title":"Lakeland Industries Cut to Neutral From Buy by DA Davidson","url":"https://stock-news.laohu8.com/highlight/detail?id=2590587916","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590587916?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:15","pubTimestamp":1765372500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LAKE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 10, 2025 08:15 ET (13:15 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","IE00B66KJ199.SGD","LAKE","IE00B19Z4B17.USD","IE0031619046.USD","BK4202","BK4568"],"gpt_icon":0},{"id":"2590357625","title":"Debate On Vaccine Safety Reaches Policy Stage - FDA Broadens Review Into Covid-19 Shot Risks In Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2590357625","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590357625?lang=en_us&edition=fundamental","pubTime":"2025-12-10 20:59","pubTimestamp":1765371540,"startTime":"0","endTime":"0","summary":"FDA widens its Covid vaccine safety review as HHS Secretary Robert F. Kennedy Jr. questions longstanding guidance and companies defend their records.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/10/CDC-Officials-Resign--Citing-Political-I.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/10/CDC-Officials-Resign--Citing-Political-I.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49302187/debate-on-vaccine-safety-reaches-policy-stage-fda-broadens-review-into-covid-19-shot-risks-in-adults","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49302187/debate-on-vaccine-safety-reaches-policy-stage-fda-broadens-review-into-covid-19-shot-risks-in-adults","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4568","BK4548","SG9999002224.SGD","LU0321505868.SGD","LU0225771236.USD","LU0234572021.USD","SG9999003800.SGD","IE0002270589.USD","LU0170899867.USD","BK4599","LU0122379950.USD","LU0289739699.SGD","LU0456855351.SGD","BK4550","LU1066053197.SGD","BK4585","SG9999011175.SGD","BK4139","LU0321505439.SGD","BK4007","LU0306806265.USD","LU1057294990.SGD","SG9999001176.USD","LU0225284248.USD","SG9999002232.USD","BK4581","BK4532","BK4501","MRNA","BK4588","LU1894683264.USD","IE000M9KFDE8.USD","PFE","SG9999001176.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","IE00BLSP4239.USD","BK4534","SG9999013999.USD","LU1883839398.USD","LU0985481810.HKD","LU0868494617.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","BNTX","LU1023059063.AUD","LU1066051498.USD","BK4533","LU0306807586.USD","BK4535","BK4551","IE00BLSP4452.SGD","LU0058720904.USD","IE00B19Z3581.USD","BK4592"],"gpt_icon":1},{"id":"2590821405","title":"Fresenius Medical Care Appoints Charles Hugh-Jones as Global Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590821405","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590821405?lang=en_us&edition=fundamental","pubTime":"2025-12-10 20:56","pubTimestamp":1765371404,"startTime":"0","endTime":"0","summary":"Fresenius Medical Care AG has appointed Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board, effective January 1, 2026. He will succeed Franklin W. Maddux, who will retire at the end of the year. Charles Hugh-Jones previously served as CEO of Volastra Therapeutics and held senior roles at Allergan, Pfizer, and Sanofi.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief on December 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL6WVYfm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0868494617.USD","LU0456855351.SGD","LU1894683264.USD","BK4533","LU0321505868.SGD","SG9999001176.USD","IE00BLSP4452.SGD","LU1023059063.AUD","SG9999002224.SGD","SG9999013999.USD","BK4588","BK4568","LU1894683348.USD","LU1883839398.USD","IE0002270589.USD","IE00BBT3K403.USD","LU0225771236.USD","LU0321505439.SGD","BK4592","LU0289739699.SGD","FMS","BK4581","BK4599","SG9999011175.SGD","IE000M9KFDE8.USD","BK4534","LU0058720904.USD","SG9999002232.USD","SG9999001176.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4007","LU1066051498.USD","IE00BLSP4239.USD","LU0225284248.USD","LU1066053197.SGD","BK4585","LU0306807586.USD","LU0122379950.USD","LU0306806265.USD","SG9999003800.SGD","BK4550","LU0170899867.USD","IE00B19Z3581.USD","SGXZ57979304.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":13,"totalSize":309,"code":"91000000","status":"200"}]}}